 This is a multicenter randomized trial in which patients diagnosed with calcific aortic stenosis AS with planned AVR will be randomized to 1 the treatment arm of the Edwards Life Science filter and cannula or the filter as a stand alone with any cannula or 2 to the treatment arm of the CardioGard cannula versus 3 standard care in a 1:1:1 ratio. 